Skip to main content

Peer Review reports

From: The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis B

Original Submission
23 Mar 2022 Submitted Original manuscript
7 May 2022 Reviewed Reviewer Report
19 May 2022 Reviewed Reviewer Report
26 May 2022 Author responded Author comments - Hongmei Xu
Resubmission - Version 2
26 May 2022 Submitted Manuscript version 2
1 Jun 2022 Reviewed Reviewer Report
16 Jun 2022 Author responded Author comments - Hongmei Xu
Resubmission - Version 3
16 Jun 2022 Submitted Manuscript version 3
16 Jun 2022 Author responded Author comments - Hongmei Xu
Resubmission - Version 4
16 Jun 2022 Submitted Manuscript version 4
Publishing
27 Jun 2022 Editorially accepted
20 Jul 2022 Article published 10.1186/s12887-022-03482-0

You can find further information about peer review here.

Back to article page